The effect of light at a defined wavelength range on human tissue (therapeutic light waves) has been known and researched for almost a century. Nobel laureate Otto Warburg demonstrated the effect of light on cellular activity and respiration, and discovered cytochrome C and its importance in regeneration processes.
Hartmut Michel, Nobel Prize winner in 1988, defined this further – every breath of oxygen we breathe in is the oxygen that acts as a terminal electron acceptor on cytochrome C oxidase to allow cellular respiration.
Low-level laser therapy (LLLT, or laser needling) is a very gentle, effective and risk-free treatment, where the needle is only a beam of light.
Activating cytochrome C oxidase and the oxidative chain in injured tissue using LLLT (low-level laser therapy) (Karu, 1999) (Chen AC-H, 2011) involves a standardised treatment that applies up to ten laser applicators at laser frequencies of 660 nm and 785 nm onto the lesion. The rapid succession of treatments ensures significant activation of the body’s own regeneration processes.
A noticeable reduction in pain and tissue reactions (such as stress-induced pain) usually arises after five treatments. Negative reactions in the form of a mild swelling sensation and slight soreness have been reported in rare instances, and are temporary, usually resolving themselves within the first ten days. Regeneration progress is assessed after a further fourteen days. A second series of treatments repeating regeneration stimulation may be applied if required.
The benefits of combined treatment consisting of laser therapy and PRP (platelet-rich plasma) application have been scientifically established in significantly enhancing the effect of both treatment mechanisms.